AKT has also been reported to affect osteoporosis by upregulating FOXO1 and enhancing the expression of bone turnover markers (ALP, OCN, Runx2, and Col1) and extracellular matrix mineralization (Cai et al., 2021). The gene discussed is RUNX2; the disease is osteoporosis.